Published in Proc Natl Acad Sci U S A on June 06, 2007
Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell (2009) 3.42
Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells (2008) 1.90
Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci Transl Med (2012) 1.82
Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2011) 1.73
Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury. Ann Neurol (2010) 1.67
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Stem cell imaging: from bench to bedside. Cell Stem Cell (2014) 1.49
Cell based therapies for ischemic stroke: from basic science to bedside. Prog Neurobiol (2013) 1.39
Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model. PLoS One (2009) 1.36
Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther (2009) 1.34
Cell therapy for stroke: remaining issues to address before embarking on clinical trials. Stroke (2008) 1.21
A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage (2008) 1.20
Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging. J Nanobiotechnology (2011) 1.19
Function of mesenchymal stem cells following loading of gold nanotracers. Int J Nanomedicine (2011) 1.14
In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One (2009) 1.12
In Vivo Cellular Imaging for Translational Medical Research. Curr Med Imaging Rev (2009) 1.12
Magnetic tagging of therapeutic cells for MRI. J Nucl Med (2009) 1.11
Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine (2012) 1.10
Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol (2014) 1.09
In vivo tracking of human neural stem cells with 19F magnetic resonance imaging. PLoS One (2011) 1.09
Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™. Contrast Media Mol Imaging (2010) 1.09
In vivo tracking of cellular therapeutics using magnetic resonance imaging. Expert Opin Biol Ther (2009) 1.06
Cervical spinal cord therapeutics delivery: preclinical safety validation of a stabilized microinjection platform. Neurosurgery (2009) 1.06
Stem cell therapy for the spinal cord. Stem Cell Res Ther (2012) 1.05
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles. Nano Lett (2012) 1.02
Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells. Curr Pharm Des (2012) 1.01
A biological global positioning system: considerations for tracking stem cell behaviors in the whole body. Stem Cell Rev (2010) 1.01
Neuroprotection in the newborn infant. Clin Perinatol (2009) 0.99
Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat. Stem Cell Res Ther (2013) 0.99
Stem cell tracking by nanotechnologies. Int J Mol Sci (2010) 0.98
Cell delivery of therapeutic nanoparticles. Prog Mol Biol Transl Sci (2011) 0.97
Stem cell tracking using iron oxide nanoparticles. Int J Nanomedicine (2014) 0.95
The rise of cell therapy trials for stroke: review of published and registered studies. Stem Cells Dev (2013) 0.95
MHC mismatch inhibits neurogenesis and neuron maturation in stem cell allografts. PLoS One (2011) 0.93
Magnetic resonance imaging of cells in experimental disease models. Prog Nucl Magn Reson Spectrosc (2009) 0.92
Labeling stem cells with superparamagnetic iron oxide nanoparticles: analysis of the labeling efficacy by microscopy and magnetic resonance imaging. Methods Mol Biol (2012) 0.91
A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells. Transl Stroke Res (2011) 0.91
Long-term MRI tracking of dual-labeled adipose-derived stem cells homing into mouse carotid artery injury. Int J Nanomedicine (2012) 0.88
One, two, three steps toward cell therapy for stroke. Stroke (2014) 0.88
Live imaging of mouse endogenous neural progenitors migrating in response to an induced tumor. PLoS One (2012) 0.88
Formulation of novel lipid-coated magnetic nanoparticles as the probe for in vivo imaging. J Biomed Sci (2009) 0.88
Stem cells for brain repair in neonatal hypoxia-ischemia. Childs Nerv Syst (2013) 0.87
Clinical translation of human neural stem cells. Stem Cell Res Ther (2013) 0.87
Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brain. J Nanobiotechnology (2015) 0.85
Neural precursors exhibit distinctly different patterns of cell migration upon transplantation during either the acute or chronic phase of EAE: a serial MR imaging study. Magn Reson Med (2011) 0.85
Superparamagnetic iron oxide nanoparticle-labeled cells as an effective vehicle for tracking the GFP gene marker using magnetic resonance imaging. Cytotherapy (2009) 0.84
Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci (2012) 0.83
Manufacturing neurons from human embryonic stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy. Regen Med (2009) 0.83
Traumatic brain injury: future assessment tools and treatment prospects. Neuropsychiatr Dis Treat (2008) 0.82
Transplantation of human neural stem/progenitor cells overexpressing galectin-1 improves functional recovery from focal brain ischemia in the Mongolian gerbil. Mol Brain (2011) 0.80
Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview. Stem Cells Int (2015) 0.80
A Dual Gold Nanoparticle System for Mesenchymal Stem Cell Tracking. J Mater Chem B Mater Biol Med (2014) 0.80
A transgenic tri-modality reporter mouse. PLoS One (2013) 0.80
Combined off-resonance imaging and T2 relaxation in the rotating frame for positive contrast MR imaging of infection in a murine burn model. J Magn Reson Imaging (2010) 0.80
Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model. Stem Cell Reports (2015) 0.79
Magnetofection Mediated Transient NANOG Overexpression Enhances Proliferation and Myogenic Differentiation of Human Hair Follicle Derived Mesenchymal Stem Cells. Bioconjug Chem (2015) 0.79
Magnetic resonance imaging of transplanted stem cell fate in stroke. J Res Med Sci (2014) 0.78
Measuring collective cell movement and extracellular matrix interactions using magnetic resonance imaging. Sci Rep (2013) 0.78
Cell tracking technologies for acute ischemic brain injury. J Cereb Blood Flow Metab (2015) 0.78
Multimodality molecular imaging of stem cells therapy for stroke. Biomed Res Int (2013) 0.78
Endogenous cerebellar neurogenesis in adult mice with progressive ataxia. Ann Clin Transl Neurol (2014) 0.77
Monitoring ferumoxide-labelled neural progenitor cells and lesion evolution by magnetic resonance imaging in a model of cell transplantation in cerebral ischaemia. F1000Res (2013) 0.77
Increased Understanding of Stem Cell Behavior in Neurodegenerative and Neuromuscular Disorders by Use of Noninvasive Cell Imaging. Stem Cells Int (2016) 0.76
In Vivo Fate Imaging of Intracerebral Stem Cell Grafts in Mouse Brain. PLoS One (2015) 0.76
Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases. Mol Neurobiol (2016) 0.76
Tracking stem cells with superparamagnetic iron oxide nanoparticles: perspectives and considerations. Int J Nanomedicine (2017) 0.76
Stem Cells and Labeling for Spinal Cord Injury. Int J Mol Sci (2016) 0.75
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury. Int J Mol Sci (2016) 0.75
The effect of magnetic nanoparticles on neuronal differentiation of induced pluripotent stem cell-derived neural precursors. Int J Nanomedicine (2016) 0.75
Siloxane Nanoprobes for Labeling and Dual Modality Functional Imaging of Neural Stem Cells. Ann Biomed Eng (2015) 0.75
Fluorescent protein-expressing neural progenitor cells as a tool for transplantation studies. PLoS One (2014) 0.75
Effects of the iron oxide nanoparticle Molday ION Rhodamine B on the viability and regenerative function of neural stem cells: relevance to clinical translation. Int J Nanomedicine (2016) 0.75
Labeling adipose derived stem cell sheet by ultrasmall super-paramagnetic Fe3O4 nanoparticles and magnetic resonance tracking in vivo. Sci Rep (2017) 0.75
Neurorestoration after stroke. Neurosurg Focus (2016) 0.75
Biological Characteristics of Fluorescent Superparamagnetic Iron Oxide Labeled Human Dental Pulp Stem Cells. Stem Cells Int (2017) 0.75
Magnetically Responsive Bone Marrow Mesenchymal Stem Cell-Derived Smooth Muscle Cells Maintain Their Benefits to Augmenting Elastic Matrix Neoassembly. Tissue Eng Part C Methods (2016) 0.75
Immunohistochemical toolkit for tracking and quantifying xenotransplanted human stem cells. Regen Med (2014) 0.75
Current Concept of Stem Cell Therapy for Spinal Cord Injury: A Review. Korean J Neurotrauma (2016) 0.75
Stroke alters behavior of human skin-derived neural progenitors after transplantation adjacent to neurogenic area in rat brain. Stem Cell Res Ther (2017) 0.75
Biocompatibility of very small superparamagnetic iron oxide nanoparticles in murine organotypic hippocampal slice cultures and the role of microglia. Int J Nanomedicine (2017) 0.75
The effects of grafted mesenchymal stem cells labeled with iron oxide or cobalt-zinc-iron nanoparticles on the biological macromolecules of rat brain tissue extracts. Int J Nanomedicine (2017) 0.75
Multifunctional nanoscale strategies for enhancing and monitoring blood vessel regeneration. Nano Today (2012) 0.75
Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88
Long-distance neuronal migration in the adult mammalian brain. Science (1994) 8.02
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21
Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology (2003) 3.71
MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A (2004) 3.67
Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain (2005) 3.61
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A (2005) 3.56
Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45
Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci (2005) 3.38
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A (2002) 3.27
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg (2005) 2.87
Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed (2004) 2.54
Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A (1999) 2.42
Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature (1996) 2.33
Development of functional human embryonic stem cell-derived neurons in mouse brain. Proc Natl Acad Sci U S A (2005) 2.21
Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J Neurosci Res (2002) 2.07
Cellular MR imaging. Mol Imaging (2005) 2.01
Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage (2004) 1.86
Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neuroimage (2002) 1.82
Quantitative, three-dimensional analysis of granule cell dendrites in the rat dentate gyrus. J Comp Neurol (1990) 1.61
Detection threshold of single SPIO-labeled cells with FIESTA. Magn Reson Med (2005) 1.59
Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke (2002) 1.38
Nuclear magnetic resonance (NMR) imaging of iron oxide-labeled neural transplants. Exp Neurol (1993) 1.25
Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. Proc Natl Acad Sci U S A (2000) 1.20
Stem cells from the adult human brain develop into functional neurons in culture. Exp Cell Res (2003) 1.09
Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent. Brain Res (1992) 1.06
In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. Exp Neurol (2004) 0.98
AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci (2002) 13.09
Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci (2006) 12.37
Functional neurogenesis in the adult hippocampus. Nature (2002) 11.17
Inflammatory blockade restores adult hippocampal neurogenesis. Science (2003) 10.14
Synaptic scaling mediated by glial TNF-alpha. Nature (2006) 6.76
Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron (2003) 6.19
Synaptic plasticity and addiction. Nat Rev Neurosci (2007) 6.08
Irradiation induces neural precursor-cell dysfunction. Nat Med (2002) 5.46
Input-specific control of reward and aversion in the ventral tegmental area. Nature (2012) 4.60
Control of synaptic strength by glial TNFalpha. Science (2002) 4.46
RIM1alpha forms a protein scaffold for regulating neurotransmitter release at the active zone. Nature (2002) 4.37
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature (2007) 4.36
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A (2012) 4.20
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron (2011) 3.93
Striatal plasticity and basal ganglia circuit function. Neuron (2008) 3.89
Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron (2011) 3.89
Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res (2003) 3.81
LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell (2011) 3.78
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci (2007) 3.74
Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med (2011) 3.66
Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors. Nat Neurosci (2004) 3.64
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci U S A (2005) 3.56
FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell (2009) 3.54
Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci (2005) 3.38
RIM1alpha is required for presynaptic long-term potentiation. Nature (2002) 3.28
Arteriovenous malformations. Lancet (2002) 3.15
Synaptic plasticity: multiple forms, functions, and mechanisms. Neuropsychopharmacology (2007) 3.10
Excitation-neurogenesis coupling in adult neural stem/progenitor cells. Neuron (2004) 3.09
Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex. Neuron (2008) 3.07
The addicted synapse: mechanisms of synaptic and structural plasticity in nucleus accumbens. Trends Neurosci (2010) 3.02
CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci (2006) 2.95
Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg (2005) 2.87
VEGF is necessary for exercise-induced adult hippocampal neurogenesis. Eur J Neurosci (2003) 2.78
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci (2004) 2.73
Beta-catenin is critical for dendritic morphogenesis. Nat Neurosci (2003) 2.70
Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature (2012) 2.61
A developmental switch in the signaling cascades for LTP induction. Nat Neurosci (2003) 2.61
Acute and chronic cocaine-induced potentiation of synaptic strength in the ventral tegmental area: electrophysiological and behavioral correlates in individual rats. J Neurosci (2004) 2.59
Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature (2013) 2.55
Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature (2013) 2.55
Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci (2005) 2.53
Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab (2006) 2.41
Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens. Nat Neurosci (2010) 2.40
Characterizing non-Gaussian diffusion by using generalized diffusion tensors. Magn Reson Med (2004) 2.37
Distinct neuronal coding schemes in memory revealed by selective erasure of fast synchronous synaptic transmission. Neuron (2012) 2.35
Self-navigated interleaved spiral (SNAILS): application to high-resolution diffusion tensor imaging. Magn Reson Med (2004) 2.35
Cell transplantation therapy for stroke. Stroke (2007) 2.30
LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron (2009) 2.30
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
Alternative N-terminal domains of PSD-95 and SAP97 govern activity-dependent regulation of synaptic AMPA receptor function. Neuron (2006) 2.25
The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res (2005) 2.24
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J Neurosci (2005) 2.18
Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling. Neuron (2013) 2.18
Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol (2006) 2.17
Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A (2008) 2.15
Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD. Neuron (2008) 2.15
Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity. Neuron (2008) 2.15
Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci (2008) 2.15
Diffusion tensor imaging using single-shot SENSE-EPI. Magn Reson Med (2002) 2.14
Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression. Neuropharmacology (2006) 2.10
Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J Neurosci Res (2002) 2.07
Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery (2012) 2.06
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet (2008) 1.95
Exploring the regulation of human neural precursor cell differentiation using arrays of signaling microenvironments. Mol Syst Biol (2006) 1.90
Generation of silent synapses by acute in vivo expression of CaMKIV and CREB. Neuron (2005) 1.86
Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab (2008) 1.86
Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus (2008) 1.84
A critical role for PSD-95/AKAP interactions in endocytosis of synaptic AMPA receptors. Nat Neurosci (2009) 1.80
Multiple roles for the active zone protein RIM1alpha in late stages of neurotransmitter release. Neuron (2004) 1.74
Postsynaptic complexin controls AMPA receptor exocytosis during LTP. Neuron (2012) 1.74
Comprehensive qPCR profiling of gene expression in single neuronal cells. Nat Protoc (2011) 1.73
Sleep restriction suppresses neurogenesis induced by hippocampus-dependent learning. J Neurophysiol (2005) 1.72
Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci (2004) 1.71
Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone. Neuron (2011) 1.71
Neuronal pentraxins mediate synaptic refinement in the developing visual system. J Neurosci (2006) 1.71
Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell (2013) 1.70
Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem (2003) 1.69
NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol (2012) 1.67
Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology (2013) 1.67
Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One (2010) 1.66
Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies. Ann Neurol (2007) 1.64
Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc Natl Acad Sci U S A (2011) 1.63
Line scan diffusion imaging of the spine. AJNR Am J Neuroradiol (2003) 1.61
Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis (2009) 1.61
Simultaneous phase correction and SENSE reconstruction for navigated multi-shot DWI with non-cartesian k-space sampling. Magn Reson Med (2005) 1.61
Genetic analysis of Mint/X11 proteins: essential presynaptic functions of a neuronal adaptor protein family. J Neurosci (2006) 1.61
Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant (2009) 1.60
Environmental change and economic development in coastal Peru between 5,800 and 3,600 years ago. Proc Natl Acad Sci U S A (2009) 1.59
Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab (2008) 1.59
Multimodality treatment of posterior fossa arteriovenous malformations. J Neurosurg (2008) 1.59
Immune influence on adult neural stem cell regulation and function. Neuron (2009) 1.59